Target antigens of transmission blocking antibodies for Malaria parasites (1)

Type
Compound(s)

This invention relates to novel methods and compositions for blocking transmission of Plasmodium vivax which cause malaria. In particular, Pvs25 and Pvs28 polypeptides, variants and fusion proteins thereof, are disclosed which, when administered to a susceptible organism, induce an immune response against a 25 kD and 28 kD protein, respectively, on the surface of Plasmodium vivax zygotes and ookinetes. This immune response in the susceptible organism can block transmission of malaria. {RefNo is 1182 }

Disease
Malaria
Research areas
Basic research
Condition of use

n/a

IP information

Granted Patent Reference Number(s): Issued US 7,407,658 US patent will go abandoned due non payment of annuities in Feb 2012, Abandoned AU, CA, BR, EP US
Abandoned Patent Reference Number(s): Issued US 7,407,658 US patent will go abandoned due non payment of annuities in Feb 2012, Abandoned AU, CA, BR, EP US